Hlavica P, Lehnerer M, Eulitz M
Walther-Straub-Institut für Pharmakologie und Toxikologie, Universität München, Germany.
Biochem J. 1996 Sep 15;318 ( Pt 3)(Pt 3):857-62. doi: 10.1042/bj3180857.
Treatment of cytochrome P-450 2B4 (P-450 2B4) with diethylpyrocarbonate to introduce 10-11 equivalents of acylating agent per polypeptide chain resulted in the selective derivatization of histidine residues characterized by differential susceptibility toward the modifier. Second-derivative spectral analysis as well as fluorescence measurements disproved gross alterations in P-450 2B4 structure as a consequence of labelling. The modified haemoprotein retained its ability to bind hexobarbital and catalyse cumene hydroperoxide-sustained N-demethylation of the barbiturate. However, there was a steady attenuation of NAD(P)H-driven electron flux with increasing extent of P-450 2B4 carbethoxylation in reconstituted systems fortified with either NADPH-cytochrome P-450 reductase or NADH-cytochrome b5 reductase/cytochrome b5 as the redox partners, with 50% inhibition occurring when 6-7 histidines were blocked. Hampered P-450 2B4 reductase activities recovered to differing degrees upon treatment of the acylated mono-oxygenase with neutral hydroxylamine. Spectral data indicated that docking of the redox components to derivatized P-450 2B4 was not perturbed, so that disruption of the electron flows most likely resulted from some injury of the electron-transfer mechanisms.
用焦碳酸二乙酯处理细胞色素P-450 2B4(P-450 2B4),使每条多肽链引入10 - 11当量的酰化剂,导致组氨酸残基发生选择性衍生化,其特征在于对修饰剂的敏感性不同。二阶导数光谱分析以及荧光测量结果表明,标记并未导致P-450 2B4结构发生重大改变。修饰后的血红蛋白保留了结合己巴比妥以及催化异丙苯过氧化氢维持的巴比妥酸盐N-去甲基化的能力。然而,在用NADPH-细胞色素P-450还原酶或NADH-细胞色素b5还原酶/细胞色素b5作为氧化还原伴侣强化的重组系统中,随着P-450 2B4乙氧羰基化程度的增加,NAD(P)H驱动的电子通量持续衰减,当6 - 7个组氨酸被阻断时,出现50%的抑制。用中性羟胺处理酰化单加氧酶后,受抑制的P-450 2B4还原酶活性不同程度地恢复。光谱数据表明,氧化还原成分与衍生化的P-450 2B4的对接未受干扰,因此电子流的中断很可能是由电子传递机制的某些损伤导致的。